Dr. Yost is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 N. Academy Ave
Danville, PA 17821Phone+1 570-271-6211
Summary
- Gregory Yost, DO, is a cardiology specialist with a subspecialty in interventional cardiology based in Danville, PA. He completed his medical residency and fellowships in internal medicine, cardiovascular disease, and interventional cardiology at Geisinger Health System. Dr. Yost practices at Geisinger Medical Center and has experience in defibrillator implantation. He has published research on myocardial infarction, cardiac catheterization, contrast reactions before percutaneous coronary intervention, and health care delivery during the COVID-19 pandemic. Additionally, he has been involved in clinical trials such as the ARTEMIS study and trials assessing coronary stent efficacy.
Education & Training
Geisinger Health SystemFellowship, Interventional Cardiology, 2015 - 2016- Geisinger Health System (Danville)Fellowship, Cardiovascular Disease, 2012 - 2015
- Geisinger Health System (Danville)Residency, Internal Medicine, 2009 - 2012
Lake Erie College of Osteopathic Medicine - Seton HillClass of 2009
Certifications & Licensure
PA State License 2009 - 2026
American Board of Internal Medicine Cardiovascular Disease- American Board of Internal Medicine Interventional Cardiology
Certification Board of Cardiovascular Computed TomographyBoard certified Certification Board of Cardiovascular Computed Tomography- National board of echocardiography Board certified national board of echocardiography
Clinical Trials
- Disrupt CAD III With the Shockwave Coronary IVL System Start of enrollment: 2019 Jan 09
- PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease Start of enrollment: 2017 Oct 13
- ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack Start of enrollment: 2024 Jun 25
Publications & Presentations
PubMed
- Outcomes of Patients Undergoing Cardiac Catheterization After a Three-Day Holiday Weekend Versus a Two-Day Weekend.James C. Blankenship, Erin Vanenkevort, Maulin Patel, Gregory Yost, Thomas D. Scott
The Journal of Invasive Cardiology. 2021-11-03 - 4 citationsPrognostic implications of prior contrast reaction in patients with emergency premedication before undergoing percutaneous coronary intervention.Kunal K. Jha, Milad C. El Hajj, Zachariah Nealy, Uchenna R. Ofoma, Andrea Berger
International Journal of Cardiology. 2021-01-28 - 5 citationsCoronary and Structural Heart Disease Interventions During COVID-19 Pandemic: A Road Map for Clinicians and Health Care Delivery Systems.Kishore J. Harjai, Shikhar Agarwal, Terry D. Bauch, Mark Bernardi, Alfred S. Casale
Cardiovascular Revascularization Medicine. 2020-06-10
Journal Articles
- Length of stay and 30 day mortality in patients suffering an uncomplicated ST-elevation myocardial infarction treated with primary percutaneous coronary intervention i...Neil D. Shah, MD, Gregory W. Yost, DO, Edward L. Hannan, PhD, Ye Zhong, MD, Ferdinand J. Venditti, MD, David R. Holmes, Jr., MD, Nicholas Stamato, MD, Samin K. Sharma,..., Journal of Clinical and Interventional Cardiology, 1/3/2023
Authored Content
- Is 30-Day Mortality After Admission for Heart Failure an Appropriate Metric for Quality?September 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
